Yamazaki N - Search Results

1

Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study.

Namikawa K, Kiyohara Y, Takenouchi T, Uhara H, Uchi H, Yoshikawa S, Takatsuka S, Koga H, Wada N, Minami H, Hatsumichi M, Asada S, Namba Y, Yamazaki N. Namikawa K, et al. Among authors: yamazaki n. Eur J Cancer. 2018 Dec;105:114-126. doi: 10.1016/j.ejca.2018.09.025. Epub 2018 Nov 15. Eur J Cancer. 2018. PMID: 30447539 Free article. Clinical Trial.

2

[Chemotherapy of malignant melanoma].

Ishihara K, Yamazaki N, Asano K. Ishihara K, et al. Among authors: yamazaki n. Gan To Kagaku Ryoho. 1993 Aug;20(10):1287-92. Gan To Kagaku Ryoho. 1993. PMID: 7688498 Japanese.

3

Dacarbazine, nimustine hydrochloride, cisplatin and tamoxifen combination chemotherapy for advanced malignant melanoma.

Yamazaki N, Yamamoto A, Wada T, Ishikawa M. Yamazaki N, et al. J Dermatol. 1999 Aug;26(8):489-93. doi: 10.1111/j.1346-8138.1999.tb02033.x. J Dermatol. 1999. PMID: 10487002

4

Evaluation of 5-S-cysteinyldopa as a marker of melanoma progression: 10 years' experience.

Wakamatsu K, Kageshita T, Furue M, Hatta N, Kiyohara Y, Nakayama J, Ono T, Saida T, Takata M, Tsuchida T, Uhara H, Yamamoto A, Yamazaki N, Naito A, Ito S. Wakamatsu K, et al. Among authors: yamazaki n. Melanoma Res. 2002 Jun;12(3):245-53. doi: 10.1097/00008390-200206000-00008. Melanoma Res. 2002. PMID: 12140381

5

A case of sentinel node metastasis of superficial spreading melanoma with two lymphatic channels.

Yamazaki N, Namikawa K. Yamazaki N, et al. Jpn J Clin Oncol. 2008 Jan;38(1):84. doi: 10.1093/jjco/hym175. Jpn J Clin Oncol. 2008. PMID: 18258717 No abstract available.

6

Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.

Akiyama Y, Maruyama K, Tai S, Takikawa M, Ohshita C, Yamamoto A, Yamazaki N, Kiyohara Y, Yamaguchi K. Akiyama Y, et al. Among authors: yamazaki n. Int J Oncol. 2008 Sep;33(3):433-41. Int J Oncol. 2008. PMID: 18695871

7

Characterization of a MAGE-1-derived HLA-A24 epitope-specific CTL line from a Japanese metastatic melanoma patient.

Akiyama Y, Maruyama K, Tai S, Komiyama M, Iizuka A, Takikawa M, Ohshita C, Yamamoto A, Yamazaki N, Kiyohara Y, Yamaguchi K. Akiyama Y, et al. Among authors: yamazaki n. Anticancer Res. 2009 Feb;29(2):647-55. Anticancer Res. 2009. PMID: 19331215 Free article.

8

Metastatic melanoma on the abdominal wall.

Namikawa K, Yamazaki N. Namikawa K, et al. Among authors: yamazaki n. Jpn J Clin Oncol. 2009 May;39(5):336. doi: 10.1093/jjco/hyp042. Jpn J Clin Oncol. 2009. PMID: 19403735 No abstract available.

9

Characterization of cytomegalovirus pp65-HLA-A24 peptide-specific CTL lines from metastatic melanoma patients.

Akiyama Y, Tai S, Komiyama M, Takikawa M, Ohshita C, Yamamoto A, Yamazaki N, Kiyohara Y. Akiyama Y, et al. Among authors: yamazaki n. Oncol Rep. 2009 Jul;22(1):185-91. doi: 10.3892/or_00000423. Oncol Rep. 2009. PMID: 19513522

10

Identification of melanoma antigens using a Serological Proteome Approach (SERPA).

Suzuki A, Iizuka A, Komiyama M, Takikawa M, Kume A, Tai S, Ohshita C, Kurusu A, Nakamura Y, Yamamoto A, Yamazaki N, Yoshikawa S, Kiyohara Y, Akiyama Y. Suzuki A, et al. Among authors: yamazaki n. Cancer Genomics Proteomics. 2010 Jan-Feb;7(1):17-23. Cancer Genomics Proteomics. 2010. PMID: 20181627

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

784 results

Search Page

Filters